Searchable abstracts of presentations at key conferences in endocrinology

ea0032p807 | Paediatric endocrinology | ECE2013

Final height of a group of patients with congenital adrenal hyperplasia

Ferreira Marta , Santos Sonia , Pereira Ester , Vale Beatriz , Cardoso Rita , Dinis Isabel , Mirante Alice

Introduction: The final height of children with congenital adrenal hyperplasia (CAH) seems to be compromised. That can happen because of the disease itself or because an excessive dose of corticoids used during treatment. This work evaluates the final stature SDS of a group of patients with CAH and correlates it with 17-hydroxyprogesterone levels (17OHP) and corticoid dose at 10 years of age and at puberty onset.Methods: Selection of children with CAH di...

ea0032p796 | Paediatric endocrinology | ECE2013

Premature pubarche: distinguishing between nonclassic congenital adrenal hyperplasia and idiopathic premature adrenarche

Pereira Ester , Caetano Joana , Cardoso Rita , Ferreira Sara , Santos Sonia , Ferreira Marta , Vale Beatriz , Dinis Isabel , Mirante Alice

Introduction: Premature pubarche (PP) is most often related to idiopathic premature adrenarche (IPA). However, it is a diagnosis of exclusion and differential diagnosis must include milder and nonclassic variants of congenital adrenal hyperplasia (CAH).Purpose: To identify clinical predictors of CAH and IPA in children with PP.Materials and methods: A retrospective study was conducted including children seen for PP between 2001 and...

ea0032p797 | Paediatric endocrinology | ECE2013

Improvement in metabolic control of type 1 diabetes mellitus in a tertiary unit: 2005 vs 2012

Caetano Joana , Ferreira Sara , Pereira Ester , Ferreira Marta , Lourenco Helena , Aveiro Lina , Batista Nanci , Freitas Filomena , Simao Luisa , Cardoso Rita , Dinis Isabel , Mirante Alice

Aim: To define the main predictors of metabolic control in children and adolescents and evaluate its improvement along the years.Methods: We included children and adolescents with 1DM, with more than two years of disease. Data were collected at 2005 and at 2012. Sex, age and severity at diagnosis, therapy in the last year, age at onset of multiple daily insulin injections (MDII) and continuous subcutaneous insulin infusion (CSII), number of group educati...